Face transplant
| Face transplant | |
|---|---|
Face transplant recipient Jim Maki (left) with plastic surgeon Bohdan Pomahač | |
| MeSH | D054445 |
A facial transplant is a medical procedure in which a significant portion of tissue is grafted onto the donor recipient's face, typically involving the use of facial tissues from a deceased donor. It is a form of Vascularized Composite Tissue Allotransplantation (VCA), a surgical technique involving the transplantation of multiple types of tissues as a functional unit. Facial transplantation may include the grafting of skin, lips, facial musculature, sensory nerves, and, potentially, underlying facial bones such as those of the nose. Recipients of face transplants require lifelong immunosuppressive therapy to prevent rejection of the transplanted tissue by the immune system.
The first successful partial face transplant on a living human was performed on Isabelle Dinoire in November 2005 at the Amiens-Picardie University Hospital in France. The 15‑hour surgical operation transplanted a triangular graft comprising the nose, lips, and chin from a deceased donor onto Dinoire, who had suffered a traumatic facial injury earlier that year. The first full face transplant was completed in Spain in March 2010 by a team at Vall d'Hebron University Hospital in Barcelona, Spain, onto a male recipient with significant facial abnormalities. This was done across several procedures.
Turkey, France, the United States, and Spain are considered leading countries in performing and conducting further research into the procedure. As of 2025, it is estimated that approximately 50 facial transplants have been successfully performed internationally.
The ethical, psychosocial, and medical aspects of face transplantation are still subject to debate, particularly concerning topics such as long-term immunosuppression, changes in identity and in quality of life. In October 2019, the UK Research and Innovation (UKRI) funded AboutFace, led by British cultural historian Fay Bound Alberti (University of York). The project convened surgeons, ethicists, and patients globally to determine potential future developments in the field of facial transplantation. This groundwork contributed to a subsequent report by the National Academies of Sciences, Engineering, and Medicine (NASEM), who proposed updated guidance aiming to improve patient care and procedural outcomes.